DE602007005992D1 - Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien - Google Patents

Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien

Info

Publication number
DE602007005992D1
DE602007005992D1 DE602007005992T DE602007005992T DE602007005992D1 DE 602007005992 D1 DE602007005992 D1 DE 602007005992D1 DE 602007005992 T DE602007005992 T DE 602007005992T DE 602007005992 T DE602007005992 T DE 602007005992T DE 602007005992 D1 DE602007005992 D1 DE 602007005992D1
Authority
DE
Germany
Prior art keywords
canthin
mycobacteria
analogue
diseases
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007005992T
Other languages
English (en)
Inventor
Alain Robert Fournet
Delphine Lagoutte
Erwan Poupon
Flor Soriano-Agaton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Publication of DE602007005992D1 publication Critical patent/DE602007005992D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602007005992T 2006-03-28 2007-03-22 Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien Active DE602007005992D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602677A FR2899229B1 (fr) 2006-03-28 2006-03-28 Utilisation de la canthin-6-one et ses analogues dans le traitement des pathologies liees aux micobacteries
PCT/FR2007/000486 WO2007110500A1 (fr) 2006-03-28 2007-03-22 Utilisation de la canthin-6-one et ses analogues dans le traitement des pathologies liees aux mycobacteries

Publications (1)

Publication Number Publication Date
DE602007005992D1 true DE602007005992D1 (de) 2010-06-02

Family

ID=36979514

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007005992T Active DE602007005992D1 (de) 2006-03-28 2007-03-22 Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien

Country Status (9)

Country Link
US (1) US20110059977A1 (de)
EP (1) EP1998770B1 (de)
CN (1) CN101448499B (de)
AP (1) AP2721A (de)
AT (1) ATE464899T1 (de)
BR (1) BRPI0709673A2 (de)
DE (1) DE602007005992D1 (de)
FR (1) FR2899229B1 (de)
WO (1) WO2007110500A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES503557A0 (es) * 1980-07-03 1982-04-01 Omnichem Sa Procedimiento de preparacion de alquil-3 tetrahidro-1,2,3, 3a-4h-indolo(3,2,1-de)-1,5-naftiridinas.
CN1551761A (zh) * 2001-04-06 2004-12-01 ���ݴ�ѧУ��ίԱ�� 酰基氨基葡萄糖环己六醇酰胺酶抑制剂及其使用方法
FR2847474B1 (fr) * 2002-11-25 2006-03-24 Inst Rech Developpement Ird Utilisation de la canthin-6-one, des extraits de plantes la contenant et de ses derives dans le traitement de la maladie de chagas

Also Published As

Publication number Publication date
FR2899229A1 (fr) 2007-10-05
FR2899229B1 (fr) 2008-05-30
US20110059977A1 (en) 2011-03-10
BRPI0709673A2 (pt) 2011-07-19
ATE464899T1 (de) 2010-05-15
WO2007110500A1 (fr) 2007-10-04
CN101448499A (zh) 2009-06-03
CN101448499B (zh) 2012-09-05
AP2008004644A0 (en) 2008-10-31
EP1998770B1 (de) 2010-04-21
AP2721A (en) 2013-08-31
EP1998770A1 (de) 2008-12-10
WO2007110500A8 (fr) 2008-12-11

Similar Documents

Publication Publication Date Title
ATE448206T1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
DE602005022427D1 (de) Verwendung von flibanserin bei der behandlung von prämenstruellen störungen
ATE505472T1 (de) Pyridinderivate und ihre verwendung bei der behandlung psychotischer erkrankungen
ATE495179T1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
DK1773361T4 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
DK1765322T3 (da) Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser
CR10699A (es) Antagonistas de wnt y su uso en el diagnostico y tratamiento de trastornos mediados por wnt
ATE524479T1 (de) Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DE50306850D1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
ATE489091T1 (de) Dha-ester und ihre verwendung bei der behandlung und der prävention von kardiovaskulären erkrankungen
ATE413178T1 (de) 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen
ATE447570T1 (de) Pyrimidinderivate zur verwendung als vanilloidrezeptorliganden und deren verwendung bei der behandlung von schmerzen
ITMI20050262A1 (it) Sostanze composizioni e metodi di trattamento dell'alopecia
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
ATE483460T1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602005010222D1 (de) Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
ATE449769T1 (de) 3-(4-ää4-(4ää3-(3,3-dimethyl-1- piperidinyl)propyläoxyüphinylü-1- piperidinylcarbonylü-1-naphthalinyl)propan- oder propensäure als h1- und h3-rezeptor-antagonisten zur behandlung entzündlicher und/oder allergischer erkrankungen
DE602006010042D1 (de) Verwendung von nichtsteroidalen entzündungshemmern bei der behandlung von akuter und chronischer bronchitis
ATE479716T1 (de) Copolymerisate und ihre verwendung zur behandlung von flexiblen substraten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition